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SYNOPSIS
Objectives. We determined whether state Medicaid programs cover recommended treatments for adult and pediatric obesity and to what extent states
regulate the treatment and coverage of obesity by private insurers.
Methods. We conducted a state-by-state document review of Medicaid manuals and private insurance laws and regulations.
Results. Eight state Medicaid programs appear to cover all recommended
obesity treatment modalities for adults. Only 10 states appear to reimburse for
obesity-related treatment in children. In the small-group insurance market, 35
states expressly allow obesity to be used for rate adjustments, while 10 states
do so in the individual market. Two states expressly allow obesity to be used in
eligibility decisions in the individual market. Five states provide for coverage of
one or more treatments for obesity in both small-group and individual markets.
Conclusions. Very few states ensure coverage of recommended treatments for
adult and pediatric obesity through Medicaid or private insurance. Most states
allow obesity to be used to adjust rates in the small-group and individual
markets and to deny coverage in the individual market.
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Obesity is one of the most challenging public health
problems we face as a nation. More than 32% of American adults are obese and more than 17% of children
and adolescents are overweight.1 Obese individuals are
more likely than normal-weight individuals to develop
hypertension, heart disease, diabetes, and stroke,
among other diseases.2–8 The increasing prevalence
of obesity and its significant health consequences are
straining our health-care system. In 2000, the total cost
of obesity in the United States was an estimated $117
billion—$61 billion in direct costs and $56 billion in
indirect costs.9,10
Through Medicare and Medicaid, federal and state
governments finance approximately half of direct
medical expenditures attributable to overweight and
obesity in the U.S.11 Medicaid enrollees have the highest prevalence of obesity compared with those who are
uninsured, privately insured, or in Medicare. As a result,
11% of U.S. adult Medicaid expenditures are spent on
treating obesity-related medical conditions.12
In response to increasing obesity rates and the concomitant economic and health challenges these rates
impose, states have responded in a variety of ways. Some
have enacted tax laws that create incentives for healthy
behaviors or penalize unhealthy habits.13 Some states
have targeted competitive foods in schools and created
new physical education and fitness requirements. Local
and state governments have utilized planning, zoning, and transportation policies to promote healthier
lifestyles. But few studies have examined state policy
with regard to public or private insurance coverage of
health-care services for obesity itself.
Currently, there are no known statutes or regulations to preclude states from covering treatment for
obesity through Medicaid or private insurance. In
fact, in 2004, the Centers for Medicare and Medicaid
Services (CMS) removed language from the Medicare
Coverage Issues Manual stating obesity was not an
illness.14 And research has demonstrated that under
Medicaid, eligible children already have coverage
for comprehensive obesity services through the Early
and Periodic Screening, Diagnostic, and Treatment
(EPSDT) program.15
EPSDT program benefits include complete periodic
and as-needed assessments of children’s health and
development from birth to age 21. The examinations
include regular assessments of nutritional status, such
as height and weight measurements, and questions
about dietary practices.16 For children identified with a
health condition, states must arrange for all medically
necessary treatments falling within federally covered
service classes. Obesity assessment and treatment can
be understood to fall in these covered categories.
However, while eligible children are entitled to obe-
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sity assessment and treatment under EPSDT program
regulations, it is not clear whether states are actually
covering necessary services.
It was hoped that the 2004 CMS policy reversal
would open the door to public and private coverage
expansions of evidence-based obesity-related treatments. While more studies are needed to determine
which therapies for obesity are most effective, treatment
guidelines from the National Heart, Lung, and Blood
Institute and other professional organizations concur
in supporting specific multidisciplinary approaches
to treatment of obesity.17–21 Despite these recommendations, public and private insurance coverage for
treatment of obesity as a primary disease still appears
very limited.
Most coverage expansions thus far have focused on
bariatric surgery. CMS expanded coverage of bariatric
surgery for Medicare beneficiaries who are morbidly
obese, but beneficiaries must have a comorbid condition, such as hypertension, coronary artery disease,
osteoarthritis, or type 2 diabetes.22 Some private
insurers will also cover bariatric surgery on a limited
basis.23
Few studies have evaluated public and private insurance coverage of primary obesity treatment, especially
at the state level. In this study, we examined how
states use their lawmaking and regulatory authority
to respond to the problem of obesity. We conducted
a state-by-state analysis of (1) Medicaid and EPSDT
program coverage and payment practices for adult
and pediatric obesity assessment and treatment, (2)
the extent to which states prohibit or regulate insurers’
medical underwriting or eligibility exclusion of obesity,
and (3) the extent to which state insurance laws address
coverage of obesity treatment. In previous studies of
insurance coverage for obesity treatment, researchers
utilized surveys to collect data from private insurers
and state Medicaid programs. Our analysis is based on
an extensive document and legal review of state laws,
regulations, and provider guidance.
METHODS
Medicaid and EPSDT program analysis
We reviewed current evidence-based guidelines for adult
and pediatric obesity assessment and treatment.17–21 We
selected the following interventions for analysis of
Medicaid coverage and payment practices for adults
with obesity: nutritional assessment/counseling, drug
therapy, and bariatric surgery. For children, based on
current guidelines, we focused our search on coverage and reimbursement of nutrition and behavioral
therapies.
Based on current treatment recommendations,
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specific national medical service billing Current Procedural Terminology (CPT®) codes for obesity assessment
and treatment were selected (Figure 1). These codes
would most likely be used in billing for the nutritional,
behavioral, and surgical therapies that comprise the
bulk of treatment approaches for obesity.24,25
For each state, we reviewed Medicaid provider manuals, EPSDT program manuals, codes and regulations,
and fee schedules publicly available from state websites.
We limited our search to Medicaid fee-for-service documents and excluded managed care service contracts
from our search.26
We reviewed provider manuals for (1) provider
guidance for the assessment and treatment of obesity,
(2) coverage and reimbursement of specific obesityrelated treatments, and (3) explicit exclusions of
obesity-related assessment or treatment. Key word

searches within these documents included obesity,
weight, weight gain, morbid obesity, gastric bypass,
Roux-en-Y, orlistat, sibutramine, exenatide, pramlintide, rimonabant, gastroplasty, gastric adjustable band,
nutrition, diet, and nutritional services.
We also searched state fee schedules for the selected
CPT codes and noted which codes were associated with
a reimbursement value. Results from our document
review were compiled to grade each state based on
whether their Medicaid documents provided strong
evidence, inconclusive evidence, or specific restrictions of provider reimbursement for obesity-related
treatments.
State insurance law analysis
We reviewed state laws and regulations for private
insurance in both the individual and small-group

Figure 1. Selected billing codes used for obesity assessment and management
CPT/HCPCS-II codea

Code description

Obesity-related service

96150-96155

Health and behavior assessments (health-focused clinical
interview, behavior observations, psychophysiological
monitoring, health-oriented questionnaires)

Health and behavioral intervention/
counseling

99401-99404
99411-99412

Counseling and/or risk factor reduction intervention
(individual or group)

Obesity prevention counseling

97802-97804 and/or
S9470

Medical nutritional therapy (individual or group): nutritional
assessment and intervention by non-physician provider

Nutritional counseling

98960-98962

Education and training for patient self-management,
by non-physician

Counseling for individuals or groups
of patients with symptoms/illnesses

99078

Miscellaneous services: physician educational services to
patients in group setting

Group counseling for patients with
symptoms/illnesses

S0315-S0316

Health education disease management program: initial
and follow-up assessments

Health education

S9445-S9446

Patient education, not otherwise specified
Non-physician provider, individual or group

Health education

S9449

Weight management class, non-physician provider

Weight management class

S9451

Exercise class, non-physician provider, per session

Exercise class

S9452

Nutrition class, non-physician provider

Nutrition class

43644-43645

Laparoscopy, surgical, gastric restrictive procedure
with gastric bypass

Bariatric surgery

43770-43774

Laparoscopy, surgical, gastric restrictive procedure
involving adjustable gastric band

43842-43843

Gastric restrictive procedure, without gastric bypass,
for morbid obesity

43845

Gastric restrictive procedure with partial gastrectomy

43846-43847

Gastric restrictive procedure, with gastric bypass, for morbid
obesity

43848

Revision, open, of gastric restrictive procedure

a
The CPT code set, maintained by the American Medical Association, is used by providers to bill for medical services and procedures. HCPCS
Level II codes are used for products, supplies, and services not included in the CPT codes.

CPT 5 Current Procedural Terminology
HCPCS 5 Health Care Financing Administration Common Procedure Coding Systems
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markets (generally three to 50 employees, though
this varied by state) for (1) statutory provisions that
expressly prohibit or regulate medical insurers’ medical
underwriting or eligibility exclusion practices where
obesity or health status is used as an independent
risk factor and (2) statutory provisions mandating
coverage of obesity-related treatments. The 2004 CMS
policy change allowed obesity to be considered a medical condition, and, thus, considered under the term
“health status.”14
We conducted a state-by-state document review
of state insurance laws and regulations obtained via
Internet search of the following websites: each state’s
Department of Insurance, National Association of
Health Underwriters,27 Georgetown University Health
Policy Institute,28 National Association of Insurance
Commissioners,29 and legal searches of state insurance
codes from Westlaw and Lexis Nexis®. We searched
state legislature websites for relevant enrolled legislation that had not yet been compiled into the official
state code.
Key words included obesity, weight loss, bariatric
surgery, mandated coverage, nutritional counseling,
morbid obesity, gastric bypass, underwriting, risk
factors for underwriting, exclusions, and preexisting
conditions.
RESULTS
Specific guidelines for obesity assessment and treatment were rarely referenced in Medicaid provider
manuals. Only two state manuals referenced accepted
treatment guidelines. Nebraska and South Carolina
explicitly state in their provider manuals that obesity
is not an illness.
State Medicaid coverage of adult obesity treatment
All state Medicaid programs covered at least one obesity treatment modality. Eight states covered all three
treatment categories with various restrictions. Twentysix states explicitly covered nutritional consultation,
while 20 explicitly did not. Drug therapy was the least
frequently covered and discussed treatment category;
only 10 states covered it, while 33 states made no mention of it in their provider manuals. Bariatric surgery
was the most frequently covered treatment (45 states);
it was also the least likely to be explicitly not covered
(two states). Three states explicitly excluded nutritional
assessment/counseling and drug therapy, while covering bariatric surgery (Figure 2).



599

Figure 2. State Medicaid coverage of
adult obesity treatment modalitiesa
State

Nutritional
consultation

Drug
therapy

Bariatric
surgery

2
1b
1
0
2
2
2
1c
0
2
1
2
1b
2
1
1
2
1
1
1
0
0
1b
1
1
1b
2
2
1
2
2
2
0
1
1b
2
1
1b
1
1
1b
2
2
2
2
1
1b
1b
2
1b
2

2
2
0
0
0
1c
0
1c
0
0
2
0
0
0
1
1c
2
0
1
0
0
0
0
1c
1c
0
0
0
0
0
0
0
0
0
0
2
2
0
0
0
1c
0
0
0
0
0
1c
2
0
1c
2

1b
1c
1
1c
1c
1b
1
1c
1c
1c
1c
1c
1b
1c
1
1c
0
2
1
1c
1c
1b
1b
1c
2
1b
0
1b
1b
1b
0
1c
1b
1b,c
1c
1c
1b
1c
1c
1c
1b
1b
1
2
1c
1c
1c
1
1b,c
1c
1c

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

a
Based on an online document review of Medicaid provider manuals
and fee schedules as of July 1, 2008
b

Various restrictions apply.

Preauthorization required

c

1 5 strong evidence for coverage
0 5 not mentioned/undetermined
2 5 specifically excluded
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EPSDT coverage of pediatric obesity treatment
Most states published EPSDT-specific provider manuals
and reimbursement information. Four states included
detailed treatment standards for childhood obesity
in their EPSDT provider manuals. Nine states incorporated details on how to assess or screen for child
obesity in their EPSDT manuals, but did not include
guidelines on how to treat obesity.
We found evidence that 10 states will reimburse for
nutritional and behavioral therapy in children. These
states provided guidance in their provider manuals for
the coverage of these services, as well as reimbursement
amounts in their fee schedules for related billing codes.
Ten states did not address reimbursement of nutritional
assessment and treatment in their published materials
and did not include relevant CPT codes in their fee
schedules. In these states, these services were not likely
to be covered (Figure 3).
The majority of states provided some but not conclusive evidence that they reimbursed for nutritional
assessment and counseling. In general, these states
either provided nonspecific guidance regarding treatment for childhood conditions without listing relevant
billing codes, or they provided billing codes without
any specific language directing providers to use these
codes for nutritional assessment and treatment in the
setting of obesity.

Figure 3. State Medicaid EPSDT program coverage
of recommended childhood obesity treatmenta
Coverage of nutritional
and/or behavioral
therapy for obesity

States

Likely to be covered

Alaska, Arizona, Indiana, Iowa,
Kansas, Kentucky, Montana, New
Mexico, Oklahoma, Washington

Not likely to be covered

California, Colorado, Hawaii,
Michigan, Missouri, New Jersey,
New York, Ohio, South Dakota, Texas

Inconclusive

Alabama, Arkansas, Connecticut,
Delaware, District of Columbia,
Florida, Georgia, Idaho, Illinois,
Louisiana, Maine, Maryland,
Massachusetts, Minnesota,
Mississippi, Nebraska, Nevada,
New Hampshire, North Carolina,
North Dakota, Oregon, Pennsylvania,
Rhode Island, South Carolina,
Tennessee, Utah, Vermont, Virginia,
West Virginia, Wisconsin, Wyoming

a
Based on an online document review of Medicaid provider manuals
and fee schedules as of July 1, 2008

EPSDT 5 Early and Periodic Screening, Diagnosis, and Testing

Regulation of private insurance market
underwriting or exclusions
In the small-group market, nine states expressly prohibited the use of obesity as an independent risk factor
in medical underwriting. Thirty-five states expressly
allowed the use of obesity or health status in adjusting
rates within the small-group market. The remaining
six states and the District of Columbia were silent on
this subject.
In the individual market, only five states prohibited
the use of obesity in medical underwriting for both
eligibility determination and for determining rates
because medical underwriting was prohibited in general in these states. Oregon and Washington prohibited the use of obesity or health status in determining
rates in the individual market. Oregon and California
expressly allowed the use of obesity or health status in
determining eligibility. Ten states allowed health status
to be used as a factor in setting rates in the individual
market, with only South Dakota specifically mentioning
weight as an allowable rating factor. The remaining
states were silent on this subject (Figure 4).
Regulation of private insurance coverage
of obesity treatments
In the group market, six states required or explicitly
allowed insurers to offer coverage of certain obesity
treatments. The statutes did not specify group size. Only
Utah expressly allowed bariatric surgery to be excluded
from insurance coverage. The rest were silent.
In the individual market, five states required or
explicitly allowed insurers to offer coverage of some
obesity treatments. Illinois and South Dakota explicitly
allowed insurers to limit or exclude obesity treatments.
Utah expressly allowed the exclusion of gastric bypass
from coverage in the individual market. The remaining
state codes and regulations were silent (Figure 4).
DISCUSSION
The 2004 CMS revision of the Medicare Coverage Issues
Manual opened the door for obesity to be understood
as a medical condition in its own right.14 Public health
experts speculated that the revision would lead to
expanded Medicare coverage of obesity-related treatments, with private and public insurers following suit.
Since then, Medicare’s only expansion has been to
cover bariatric surgery for beneficiaries with comorbid
conditions who meet specific criteria. Our research
showed similar patterns at the state level.
Most states are not using their statutory or regulatory authority to expand public and private insurance
coverage of obesity assessment and treatment. Our
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Figure 4. State laws regarding private insurance coverage of
obesity treatment and underwriting based on obesitya,b
Medical underwriting or exclusions based on obesity or health status as an independent risk factor
Type of state health
insurance market
and restrictions

Statute expressly allows for rate
adjustments or exclusions

Statute expressly prohibits adjustments
in rates or exclusions

Small-group market
Rate setting

Alaska, Arizona, Arkansas, California, Colorado, Delaware,
Florida, Idaho, Illinois, Iowa, Kentucky, Louisiana, Michigan,
Minnesota, Mississippi, Missouri, Montana, Nebraska,
Nevada, New Hampshire, New Mexico, North Carolina,
North Dakota, Ohio, Oklahoma, Rhode Island, South
Carolina, South Dakota, Tennessee, Texas, Utah, Virginia,
West Virginia, Wisconsin, Wyoming

Connecticut, Maine, Maryland,
Massachusetts, New Jersey, New York,
Oregon, Vermont, Washington

Individual market
Eligibility

California, Oregon

Maine, Massachusetts, New Jersey,
New York, Vermont

Individual market
Rate setting

California, Idaho, Kentucky, Louisiana, Minnesota, Nevada,
South Carolina, South Dakota, Texas, Utah

Maine, Massachusetts, New Jersey,
New York, Oregon, Vermont, Washington

State laws regarding coverage of one or more obesity-related treatments
Statute expressly prohibits coverage
of obesity-related treatment(s)

Statute expressly allows coverage
of obesity-related treatment(s)

Small-group marketc

Utah

Georgia, Indiana, Maryland, New Hampshire,
New Jersey, Virginia

Individual market

Illinois, South Dakota, Utah

Georgia, Maryland, New Hampshire,
New Jersey, Virginia

As of July 1, 2008

a

b

States not listed had no relevant statute.

Statutes for the six listed states allowing coverage of obesity-related treatment do not specify group size.

c

findings indicate only a minority of states cover all
recommended therapies for obesity under Medicaid
or EPSDT. In the private insurance market, few states
have passed legislation requiring coverage of obesity
treatments or protection against the use of obesity in
medical underwriting. In fact, some states expressly
exclude coverage of certain obesity treatments or
expressly allow obesity to be used in determining eligibility for insurance coverage.
Medicaid coverage of recommended
treatment for obesity
Forty-five state Medicaid programs cover bariatric
surgery with various restrictions. This is consistent
with other sources reporting that 44 states covered
gastric bypass surgery.30 We found only 10 states that
explicitly covered weight-loss drugs under Medicaid;
the remaining states were either silent on the issue
or excluded weight-loss drugs. This is understandable because under federal law, weight-loss drugs are
one of the classes of drugs that Medicaid programs
can exclude from coverage.31 However, our findings
differ significantly from previous reports that found

anywhere from 17 to 38 states covered at least one
weight-loss drug under Medicaid.32–34 Most likely, these
variations are due to differences in methodology—one
report utilized a survey of Medicaid directors, another
reported data provided by pharmaceutical companies,
and the last did not report the methodology used. We
might expect to find fewer states with weight-loss drug
coverage from our strict document review.
We found evidence that 26 state Medicaid programs
covered nutritional assessment and consultation for
obesity. Our findings are generally consistent with those
of Tsai et al., who found that eight out of 14 surveyed
state Medicaid programs offered consultation with a
nutritionist or dietitian to their enrollees.35 Almost all
the programs Tsai and colleagues surveyed offered
dietitian referral only if the patient had an obesityrelated medical condition. Eleven of the 26 states we
found included various restrictions. We also found 20
state Medicaid programs that explicitly exclude nutritional services for enrollees.
In contrast, the majority of Medicaid programs will
cover bariatric surgery for their enrollees, with restrictions. Surgery is also less likely to be explicitly excluded
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under Medicaid. Between 1998 and 2002, the number
of bariatric surgeries covered by Medicaid increased
by more than 260%. During the same time period,
surgeries financed by Medicare increased by more
than 280%, while those by private insurers increased
by more than 480%.36
In covering bariatric surgery, state Medicaid programs may be following the pattern of Medicare. However, practice guidelines recommend that clinicians
screen all adult patients for obesity and offer intensive
counseling and behavioral intervention to promote
sustained weight loss for obese adults. It is interesting to note that state Medicaid programs continue to
reimburse for expensive bariatric surgery, but often do
not cover less invasive and less expensive nutritional
or pharmacological therapies.
Nutritional and behavioral counseling in overweight
patients can decrease the incidence of future complications such as diabetes.37 Additionally, lifestyle and
behavioral therapies are just as cost-effective as bariatric
surgery, and more effective than drug therapy, although
cost-effectiveness varies greatly based on the risk status
of the population and the type of intervention.38,39
Despite evidence of effective primary treatments for
obesity and the heavy burden of obesity-related complications on Medicaid programs, there is very limited
reimbursement for assessment and primary treatment
of obesity. Even after the CMS policy change, most
state Medicaid programs do not appear to be treating
obesity as a disease in its own right.
Medicaid coverage of childhood obesity
assessment and treatment
Childhood obesity is associated with significant health
problems and is an important early risk factor for much
of adult morbidity and mortality. Thus, the potential
future health-care costs associated with pediatric obesity and its comorbidities are immense and should not
be ignored. Medicaid-eligible children are entitled
to ongoing nutritional assessment and management,
including obesity services, through the EPSDT program. Even when specific treatments for obesity are
excluded for adults, Medicaid requires participating
states to cover EPSDT benefits for all eligible children
younger than age 21. In covering health treatments for
children, states are expected to adhere to standards
of medical necessity that reflect accepted pediatric
standards of care.
Evidence-based guidelines point to the importance
of regular screening and intensive behavioral and
dietary intervention early in a child’s life to prevent
and reverse the deleterious effects of overweight and
obesity. All of the recommended prevention, assess-

ment, and treatment guidelines should be covered
as part of the EPSDT benefit for eligible children.
However, we found evidence that only 11 states would
cover obesity-related nutritional and behavioral therapy
through the EPSDT program. Even fewer states published any detailed screening or treatment guidelines
for childhood obesity for their providers.
Despite the high prevalence of childhood obesity,
many physicians are not providing care that is consistent
with recommendations to prevent, screen, and manage
childhood obesity.40,41 Through the EPSDT program,
states have the statutory directive and infrastructure to
target a high-risk pediatric population and promote
evidence-based guidelines. Our findings indicate that,
unfortunately, states are not fully leveraging EPSDT
programs to fight childhood overweight and obesity.
State regulation of insurers’ obesity-related practices
About 68% of Americans obtain health-care benefits
through private health insurance plans, many of which
are regulated at the state level.42 Some states require
insurers to offer specific health benefits or access to
certain types of providers. Other state regulations
affect the rating rules that insurers use to set premiums
or to evaluate people for coverage through medical
underwriting.
Privately insured people are overwhelmingly insured
in the employer-based group market, with only 6%
of insured people covered through the individual
market.43 In the small-group market, we found that 41
states and the District of Columbia either explicitly or
implicitly allow insurers to use health status or obesity
as an independent factor in determining rates. Only
nine states require small-group health plans to use a
community or an adjusted community rating, where
the premiums would be based on the expected claims
of the community, not the individual employer group.
These findings are consistent with the consumer
information available from the National Association
of Health Underwriters.27
Thus, in most states, an employer’s health insurance premiums can be affected by the weight of his or
her employees. Obesity carries high health-care costs;
thus, as obesity rates rise, increasing health insurance
premiums may lead employers to drop health insurance coverage, increase premiums and cost-sharing for
employees, or lower wages for workers.
In the individual market, medical underwriting is
prevalent, and there is little regulation when it comes
to determining eligibility for coverage and rate setting. For example, a survey by the Texas Office of
Public Insurance Counsel in 2007 found that 100% of
surveyed individual health insurance plans used body
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mass index (BMI) as a basis to deny coverage, 86%
used BMI to charge a higher premium, and 14% used
BMI to limit benefits.44
We found that in 45 states and the District of
Columbia, no legislation protects individuals from
being denied health insurance based on obesity or
health status. When it comes to rate setting, 43 states
and the District of Columbia allow rates to be set based
on health status or obesity. If an obese patient does
manage to obtain individual health insurance, there is
no guarantee that obesity-related treatment would be
covered under his or her health plan. We found very
few states that mandated insurance coverage of any
obesity-related treatments.
The majority of state codes are silent on the coverage
of obesity treatment for both the group and individual
insurance markets. Those states that do require or
allow insurers to offer coverage mention a range of
treatments—from an annual consultation to discuss
weight and nutrition in New Jersey to coverage of
bariatric surgery in Maryland.45–47 Georgia allows insurance companies to offer coverage for non-experimental
forms of obesity therapy.48
In short, despite the change in CMS policy regarding obesity, the private insurance market remains fairly
unregulated in regard to the treatment of obesity as a
factor in eligibility and underwriting. Additionally, very
few states have mandated private insurance coverage
of obesity therapies. In fact, some states have moved
in the opposite direction, expressly allowing weight to
be used as a rating factor or allowing insurers to not
cover bariatric surgery.
Limitations
Other researchers have relied on surveys of health
plans or state Medicaid administrators to obtain
coverage information. We conducted an extensive
document review of current Medicaid manuals, fee
schedules, state insurance codes, and regulations.
Our assessment of coverage policy was based solely
on this written evidentiary review. If the actual coverage policy or fee schedule for the treatment modality
was misrepresented or not updated in the provider
manuals at the time of our review, we may have scored
the state incorrectly. Therefore, our analysis may have
been more stringent than previous researchers. However, our review also reflected the actual documented
information regarding obesity treatment guidelines or
coverage policy that is publicly available to a provider
of Medicaid or EPSDT services in the state. We find it
valuable for what it reveals in this regard. Future studies
comparing results of our document review with surveys
of health plans or state officials may be useful.
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In the adult Medicaid analysis, we limited our analysis to coverage of nutritional counseling and did not
include behavioral counseling, as there were limited
data on reimbursement of this service as it related
specifically to obesity. We also chose not to include
managed care organization (MCO) contracts in our
document review. In accordance with federal law, most
Medicaid MCOs offer at least the services covered
under fee-for-service programs.49 However, as Tsai et
al. found, some Medicaid MCOs may offer additional
services for obesity treatment that state Medicaid
programs do not.35 Thus, it is possible that Medicaid
enrollees may have access to more obesity treatment
services through their MCOs than we found in our
study of fee-for-service programs alone.
CONCLUSIONS
Our findings suggest that most states are not ensuring
recommended screening and treatment of adults and
children for obesity through Medicaid, the EPSDT
program, or private insurance. Additionally, most states
are not regulating the insurance market with regard to
use of obesity in medical underwriting. With the current economic downturn, many states are experiencing
budget deficits and are unlikely to expand coverage of
obesity treatments or enact coverage mandates in the
near future. However, given the grave economic and
health consequences of the growing obesity problem,
states should recognize the need for stronger action
sooner rather than later.
This study was funded by Trust for America’s Health. The authors
thank Laura Cohen for helping with research and data collection.
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